SPTAN1 and neoplasm: The trend of improved survival in the SPTAN1-high group was maintained after adjusting for patient age and tumour stage in a multivariable proportional hazards model (hazard ratio in the SPTAN1-high group, 0.59; 95% confidence interval, 0.35 to 1.01; p = 0.054) (Table 1).